搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Burkholderia thailandensis Arginine--tRNA ligase (argS), partial CSB-YP652663BAAJ
CSB-EP652663BAAJ
CSB-BP652663BAAJ
CSB-MP652663BAAJ
CSB-EP652663BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia thailandensis UPF0271 protein BTH_I0228 (BTH_I0228) CSB-YP652664BAAJ
CSB-EP652664BAAJ
CSB-BP652664BAAJ
CSB-MP652664BAAJ
CSB-EP652664BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia thailandensis Glutamyl-tRNA (Gln) amidotransferase subunit A (gatA) CSB-YP652665BAAJ
CSB-EP652665BAAJ
CSB-BP652665BAAJ
CSB-MP652665BAAJ
CSB-EP652665BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia thailandensis Hemin import ATP-binding protein HmuV (hmuV) CSB-YP652666BAAJ
CSB-EP652666BAAJ
CSB-BP652666BAAJ
CSB-MP652666BAAJ
CSB-EP652666BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia thailandensis Probable L-aspartate dehydrogenase (nadX) CSB-YP652667BAAJ
CSB-EP652667BAAJ
CSB-BP652667BAAJ
CSB-MP652667BAAJ
CSB-EP652667BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia thailandensis Glycogen synthase (glgA), partial CSB-YP652668BAAJ
CSB-EP652668BAAJ
CSB-BP652668BAAJ
CSB-MP652668BAAJ
CSB-EP652668BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia thailandensis Tryptophan synthase alpha chain (trpA) CSB-YP652669BAAJ
CSB-EP652669BAAJ
CSB-BP652669BAAJ
CSB-MP652669BAAJ
CSB-EP652669BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia thailandensis Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP652670BAAJ
CSB-EP652670BAAJ
CSB-BP652670BAAJ
CSB-MP652670BAAJ
CSB-EP652670BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia thailandensis ATP synthase subunit beta 2 (atpD2), partial CSB-YP652671BAAJ
CSB-EP652671BAAJ
CSB-BP652671BAAJ
CSB-MP652671BAAJ
CSB-EP652671BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Burkholderia thailandensis Chemotaxis response regulator protein-glutamate methylesterase 2 (cheB2) CSB-YP652672BAAJ
CSB-EP652672BAAJ
CSB-BP652672BAAJ
CSB-MP652672BAAJ
CSB-EP652672BAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Protein fem-1 homolog C (fem1c), partial CSB-YP652673XBE
CSB-EP652673XBE
CSB-BP652673XBE
CSB-MP652673XBE
CSB-EP652673XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Uncharacterized protein C11orf63 homolog, partial CSB-YP652674BO
CSB-EP652674BO
CSB-BP652674BO
CSB-MP652674BO
CSB-EP652674BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Nuclear autoantigenic sperm protein (NASP), partial CSB-YP652675BO
CSB-EP652675BO
CSB-BP652675BO
CSB-MP652675BO
CSB-EP652675BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Omega-amidase NIT2 (NIT2) CSB-YP652676BO
CSB-EP652676BO
CSB-BP652676BO
CSB-MP652676BO
CSB-EP652676BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine DNA-directed RNA polymerases I, II, and III subunit RPABC1 (POLR2E) CSB-YP652677BO
CSB-EP652677BO
CSB-BP652677BO
CSB-MP652677BO
CSB-EP652677BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine tRNA (adenine (58)-N (1))-methyltransferase non-catalytic subunit TRM6 (TRMT6) CSB-YP652678BO
CSB-EP652678BO
CSB-BP652678BO
CSB-MP652678BO
CSB-EP652678BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Actin-like protein 9 (ACTL9) CSB-YP652679BO
CSB-EP652679BO
CSB-BP652679BO
CSB-MP652679BO
CSB-EP652679BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Uncharacterized protein C7orf61 homolog CSB-YP652680BO
CSB-EP652680BO
CSB-BP652680BO
CSB-MP652680BO
CSB-EP652680BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Uncharacterized protein C20orf195 homolog CSB-YP652681BO
CSB-EP652681BO
CSB-BP652681BO
CSB-MP652681BO
CSB-EP652681BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Spermatogenesis-associated protein 22 (SPATA22) CSB-YP652682BO
CSB-EP652682BO
CSB-BP652682BO
CSB-MP652682BO
CSB-EP652682BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>